| Issue |
Section |
Title |
File |
| Vol 31, No 10 (2024) |
Anti-Infectives and Infectious Diseases |
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses |
(Eng)
|
| Vol 31, No 3 (2024) |
Anti-Infectives and Infectious Diseases |
First Approval of Adagrasib for the Treatment of Non-Small Cell Lung Cancer Harboring a KRASG12C Mutation |
(Eng)
|
| Vol 31, No 30 (2024) |
Anti-Infectives and Infectious Diseases |
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults |
(Eng)
|
| Vol 31, No 33 (2024) |
Anti-Infectives and Infectious Diseases |
New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease |
(Eng)
|
| Vol 31, No 34 (2024) |
Anti-Infectives and Infectious Diseases |
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases |
(Eng)
|
| Vol 31, No 4 (2024) |
Anti-Infectives and Infectious Diseases |
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder |
(Eng)
|
| Vol 31, No 6 (2024) |
Anti-Infectives and Infectious Diseases |
Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast Growth Factor Receptors for Treatment of the Bile Duct Cancer |
(Eng)
|
| Vol 31, No 6 (2024) |
Anti-Infectives and Infectious Diseases |
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency |
(Eng)
|
| Vol 31, No 7 (2024) |
Anti-Infectives and Infectious Diseases |
First Approval of Elacestrant as a Selective Estrogen Receptor Degrader for the Treatment of Metastatic Breast Cancer |
(Eng)
|
| Vol 31, No 8 (2024) |
Anti-Infectives and Infectious Diseases |
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases |
(Eng)
|
| Vol 31, No 8 (2024) |
Anti-Infectives and Infectious Diseases |
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer |
(Eng)
|
| Vol 31, No 9 (2024) |
Anti-Infectives and Infectious Diseases |
Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) |
(Eng)
|
